Perspective from Samir Kapadia, MD
September 29, 2019
2 min read
Save

REMEDIAL III: Hydration guided by urine flow rate cuts contrast-induced acute kidney injury

Perspective from Samir Kapadia, MD
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Carlo Briguori

SAN FRANCISCO — A hydration regimen guided by urine flow rate was superior to a strategy guided by left ventricular end-diastolic pressure for reducing contrast-induced acute kidney injury in patients undergoing PCI, according to the results of the REMEDIAL III study.

For the investigator-initiated study, researchers randomly assigned 708 consecutive patients undergoing PCI who had chronic kidney disease and/or were at high risk for contrast-induced acute kidney injury to hydration with normal saline using a device (RenalGuard, RenalGuard Solutions Inc.) to assess urine flow rate or a regime based on left ventricular end-diastolic pressure (LVEDP).

The protocol for the device group was to reach a urine flow rate of at least 300 mL per hour before the procedure and to maintain a urine flow rate of at least 450 mL per hour during the procedure, while the protocol for the LVEDP group was to start hydration 1 hour before PCI and to adjust the hydration rate according to LVEDP during the procedure, Carlo Briguori, MD, PhD, chief of the laboratory of interventional cardiology at Mediterranea Cardiocentro in Naples, Italy, said during a press conference at TCT 2019. Both groups continued the regimen for 4 hours after the procedure, he said.

The primary endpoint of contrast-induced acute kidney injury or acute pulmonary edema occurred in 5.7% of the device group and 10.3% of the LVEDP group (RR = 0.56; 95% CI, 0.39-0.79; number needed to treat to prevent one event = 22), Briguori said.

“The urine flow rate-guided approach carried out by the RenalGuard system seems to be superior to the left ventricular-end-diastolic-pressure-guided regimen to prevent the composite of acute kidney injury and acute pulmonary edema in high-risk patients,” he said at the press conference. “A strict control of potassium balance is required during RenalGuard therapy.”

CKD was defined as an estimated glomerular filtration rate of 45 mL/min/1.73 m2 or less. High risk for acute kidney injury was defined as Mehran’s score of at least 11 and/or Gurm’s score of more than 7. The mean age in both groups was 74 years. The device group consisted of 66% men and the LVEDP group consisted of 59% men.

In a panel discussion at the press conference, experts debated different approaches to prevent contrast-induced acute kidney injury.

“I take a different approach; I think we should just get rid of contrast,” Gary S. Mintz, MD, senior medical adviser for the Cardiovascular Research Foundation, said. “Ziad Ali, MD, has pioneered the concept of zero-contrast PCI. More than 90% of planned zero-contrast PCIs never require even 1 cc of contrast during the procedure. They are totally imaging-guided. And if you get rid of contrast, you get rid of contrast nephropathy.” – by Erik Swain

Reference:

Briguori C, et al. Late-Breaking Trials 4. Presented at: TCT Scientific Symposium; Sept. 25-29, 2019; San Francisco.

Disclosures: Briguori reports no relevant financial disclosures. Mintz reports he received consultant fees/honoraria/speaker fees from Boston Scientific, Terumo and Volcano.